Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
Boschelli DH, Ye F, Wang YD, Dutia M, Johnson SL, Wu B, Miller K, Powell DW, Yaczko D, Young M, Tischler M, Arndt K, Discafani C, Etienne C, Gibbons J, Grod J, Lucas J, Weber JM, Boschelli F.
Boschelli DH, et al.
J Med Chem. 2001 Nov 8;44(23):3965-77. doi: 10.1021/jm0102250.
J Med Chem. 2001.
PMID: 11689083